FDA Grants Aleva Approval for IDE Study
![FDA - DBS System](https://aleva-neuro.com/wp-content/uploads/2021/12/Complete-System-13_rework-1024x790.jpg)
U.S. FDA grants Aleva Neurotherapeutics approval for an Investigational Device Exemption (IDE) study on directSTIM™ Directional Deep Brain Stimulation System Aleva is committed to starting the PMA trial in the next quarters, in parallel with the post-market clinical follow-up study currently underway in select European neurological clinics. The US trial will include up to 15 […]